Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

FDA approves NILOTINIB from TORRENT

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 33
  • 0 comments

Final approval of ANDA #ANDA #218532 for NILOTINIB. Decision date: 12/15/2025

Comment Full text

FDA updates labeling for CLOMIPHENE CITRATE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 36
  • 0 comments

Labeling changes approved for COSETTE. Active ingredient: CLOMIPHENE CITRATE. Decision date: 12/18/2025

Comment Full text

FDA regulatory update for ENHERTU

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 51
  • 0 comments

Administrative update #SUPPL-38 for DAIICHI SANKYO. Status: Approval. Decision date: 12/15/2025

Comment Full text

FDA updates labeling for ACETAMINOPHEN AND IBUPROFEN

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 47
  • 0 comments

Labeling changes approved for GRANULES. Active ingredient: ACETAMINOPHEN; IBUPROFEN. Decision date: 12/17/2025

Comment Full text

FDA updates labeling for FLONASE SENSIMIST ALLERGY RELIEF

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 46
  • 0 comments

Labeling changes approved for HALEON US HOLDINGS. Active ingredient: FLUTICASONE FUROATE. Decision date: 12/19/2025

Comment Full text

FDA updates labeling for HYDROCODONE BITARTRATE AND ACETAMINOPHEN

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 28
  • 0 comments

Labeling changes approved for PRINSTON INC. Active ingredient: ACETAMINOPHEN; HYDROCODONE BITARTRATE. Decision date: 12/15/2025

Comment Full text

FDA updates labeling for WAINUA (AUTOINJECTOR)

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 48
  • 0 comments

Labeling changes approved for ASTRAZENECA AB. Active ingredient: EPLONTERSEN SODIUM. Decision date: 12/17/2025

Comment Full text

FDA updates labeling for TESTOSTERONE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 44
  • 0 comments

Labeling changes approved for ENCUBE. Active ingredient: TESTOSTERONE. Decision date: 12/17/2025

Comment Full text

FDA approves NITROGLYCERIN from SOLARIS PHARMA CORP

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 45
  • 0 comments

Final approval of ANDA #ANDA #218756 for NITROGLYCERIN. Decision date: 12/18/2025

Comment Full text

FDA approves EXDENSUR from GLAXOSMITHKLINE LLC

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 31
  • 0 comments

Final approval of BLA #BLA #761458 for DEPEMOKIMAB-ULAA. Decision date: 12/16/2025

Comment Full text
  • Previous
  • 29
  • 30
  • 31
  • 32
  • 33
  • Next

Search

News categories

  • Technical Exchange News(13198)
  • Event(6229)
  • SEC News(332736)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(185264)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin